SCHEMBL173758

SCHEMBL173758

COc1ccccc1NC(=O)Nc1cccc2c1CCN2

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.53
POLB P06746 1/20 0.52
MAPT P10636 5/20 0.51
RAB9A P51151 4/20 0.51
NPC1 O15118 3/20 0.51
LPAR1 Q92633 1/20 0.51
ALDH1A1 P00352 2/20 0.50
AHR P35869 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
KDM4E B2RXH2 2/20 0.49
GFER P55789 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
HSD17B10 Q99714 1/20 0.49
HTT P42858 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL174473 0.88 MEN1 (0.55) SMN1; SMN2MAPTRAB9ANPC1ALDH1A1
SCHEMBL167730 0.86 MEN1 (0.57) POLBMAPTRAB9ANPC1ALDH1A1
SCHEMBL175118 0.83 RAB9A (0.58) SMN1; SMN2MAPTRAB9ANPC1ALDH1A1
SCHEMBL174238 0.83 DDX3X (0.52) POLBMAPTRAB9ANPC1ALDH1A1
SCHEMBL175262 0.82 SMN1; SMN2 (0.55) SMN1; SMN2POLBMAPTRAB9ANPC1
SCHEMBL27807412 0.82 MAPT (0.51) SMN1; SMN2POLBMAPTRAB9ANPC1
SCHEMBL4569778 0.81 MEN1 (0.53) SMN1; SMN2POLBMAPTRAB9ANPC1
SCHEMBL175199 0.80 HTT (0.51) MAPTRAB9ANPC1ALDH1A1MEN1
Trifluoroacetic Acid SCHEMBL167491 0.80 KMT2A (0.50) POLBMAPTRAB9ANPC1ALDH1A1
SCHEMBL15077842 0.79 IGF1R (0.48) POLBMAPTRAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP claimed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO claimed
EP-2611806-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS Ascepion Pharmaceuticals, Inc. (CN) 2013-07-10 EP disclosed
WO-2012028106-A1 DEUTERIUM-ENRICHED HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS ASCEPION PHARMACEUTICALS, INC. (CN) 2012-03-08 WO disclosed